|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zang QQ, Zhang L, Gao N and Huang C:
Ophiopogonin D inhibits cell proliferation, causes cell cycle
arrest at G2/M, and induces apoptosis in human breast carcinoma
MCF-7 cells. J Integr Med. 14:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang Y, Zhu F, Zhang H, Chen D, Zhang X,
Gao Q and Li Y: Conditional ablation of TGF-β signaling inhibits
tumor progression and invasion in an induced mouse bladder cancer
model. Sci Rep. 6:294792016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun S, Xu A, Yang G and Cheng Y: Galanin
is a novel epigenetic silenced functional tumor suppressor in renal
cell carcinoma. Cancer Translational Medicine. 1:183–187. 2015.
View Article : Google Scholar
|
|
7
|
Cheng Y, Tu Y and Liang P: Promoter
methylated tumor suppressor genes in glioma. Cancer Translational
Medicine. 1:123–130. 2015. View Article : Google Scholar
|
|
8
|
Mani A and Gelmann EP: The
ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol.
23:4776–4789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pal A and Donato NJ: Ubiquitin-specific
proteases as therapeutic targets for the treatment of breast
cancer. Breast Cancer Res. 16:4612014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen D, Dai C and Jiang Y: Histone H2A and
H2B deubiquitinase in developmental disease and cancer. Cancer
Translational Med. 1:170–175. 2015. View Article : Google Scholar
|
|
11
|
Reyes-Turcu FE, Ventii KH and Wilkinson
KD: Regulation and cellular roles of ubiquitin-specific
deubiquitinating enzymes. Annu Rev Biochem. 78:363–397. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakagawa T, Kajitani T, Togo S, Masuko N,
Ohdan H, Hishikawa Y, Koji T, Matsuyama T, Ikura T, Muramatsu M and
Ito T: Deubiquitylation of histone H2A activates transcriptional
initiation via trans-histone cross-talk with H3K4 di- and
trimethylation. Genes Dev. 22:37–49. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Chen C, Hou X, Gao Y, Lin F, Yang
J, Gao Z, Pan L, Tao L, Wen C, et al: Identification of the E3
deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a
positive regulator of the transcription factor GATA3. J Biol Chem.
288:9373–9382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sippl W, Collura V and Colland F:
Ubiquitin-specific proteases as cancer drug targets. Future Oncol.
7:619–632. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saxena M and Yeretssian G: NOD-like
receptors: Master regulators of inflammation and cancer. Front
Immunol. 5:3272014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yimam M, Lee YC, Moore B, Jiao P, Hong M,
Nam JB, Kim MR, Hyun EJ, Chu M, Brownell L and Jia Q: Analgesic and
anti-inflammatory effects of UP1304, a botanical composite
containing standardized extracts of Curcuma longa and Morus alba. J
Integr Med. 14:60–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wertz IE, O'Rourke KM, Zhou H, Eby M,
Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, et al:
De-ubiquitination and ubiquitin ligase domains of A20 downregulate
NF-kappaB signalling. Nature. 430:694–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tzimas C, Michailidou G, Arsenakis M,
Kieff E, Mosialos G and Hatzivassiliou EG: Human ubiquitin specific
protease 31 is a deubiquitinating enzyme implicated in activation
of nuclear factor-kappaB. Cell Signal. 18:83–92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang
H, Lu XB, Fu SB and Yang J: USP4 targets TAK1 to downregulate
TNFα-induced NF-κB activation. Cell Death Differ. 18:1547–1560.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun W, Tan X, Shi Y, Xu G, Mao R, Gu X,
Fan Y, Yu Y, Burlingame S, Zhang H, et al: USP11 negatively
regulates TNFalpha-induced NF-kappaB activation by targeting on
IkappaBalpha. Cell Signal. 22:386–394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu G, Tan X, Wang H, Sun W, Shi Y,
Burlingame S, Gu X, Cao G, Zhang T, Qin J and Yang J:
Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor
alpha-induced nuclear factor kappaB activation via binding to and
deubiquitinating receptor-interacting protein 1. J Biol Chem.
285:969–978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pei M, Chen D, Li J and Wei L: Histone
deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell
chondrogenesis but inhibits chondrogenically differentiated stem
cell hypertrophy. Differentiation. 78:260–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu XX, Yan YW, Chen D, Ai CZ, Lu X, Xu
SS, Jiang S, Zhong GS, Chen DB and Jiang YZ: Long non-coding RNA
HoxA-AS3 interacts with EZH2 to regulate lineage commitment of
mesenchymal stem cells. Oncotarget. 2016.(Epub ahead of print).
doi: 10.18632/oncotarget.11538.
|
|
24
|
Chen Y, Wang M, Chen D, Wang J and Kang N:
Chromatin remodeling enzyme CHD7 is necessary for osteogenesis of
human mesenchymal stem cells. Biochem Biophys Res Commun.
478:1588–1593. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen D, Jarrell A, Guo C, Lang R and Atit
R: Dermal β-catenin activity in response to epidermal Wnt ligands
is required for fibroblast proliferation and hair follicle
initiation. Development. 139:1522–1533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Budnick I, Hamburg-Shields E, Chen D,
Torre E, Jarrell A, Akhtar-Zaidi B, Cordovan O, Spitale RC,
Scacheri P and Atit RP: Defining the identity of mouse embryonic
dermal fibroblasts. Genesis. 54:415–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng L, Hu Y, Chen D, Jiao S and Sun S:
Ubiquitin specific peptidase 21 regulates interleukin-8 expression,
stem-cell like property of human renal cell carcinoma. Oncotarget.
2016.(Epub ahead of print). doi: 10.18632/oncotarget.9751.
View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johansson P, Pavey S and Hayward N:
Confirmation of a BRAF mutation-associated gene expression
signature in melanoma. Pigment Cell Res. 20:216–221. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anders C and Carey LA: Understanding and
treating triple-negative breast cancer. Oncology (Williston Park).
22:1233–1240, 1243. 2008.PubMed/NCBI
|
|
34
|
Hartman ZC, Poage GM, den Hollander P,
Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck
SG, Mills GB and Brown PH: Growth of triple-negative breast cancer
cells relies upon coordinate autocrine expression of the
proinflammatory cytokines IL-6 and IL-8. Cancer Res. 73:3470–3480.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singel SM, Batten K, Cornelius C, Jia G,
Fasciani G, Barron SL, Wright WE and Shay JW: Receptor-interacting
protein kinase 2 promotes triple-negative breast cancer cell
migration and invasion via activation of nuclear factor-kappaB and
c-Jun N-terminal kinase pathways. Breast Cancer Res. 16:R282014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tao L, Chen C, Song H, Piccioni M, Shi G
and Li B: Deubiquitination and stabilization of IL-33 by USP21. Int
J Clin Exp Pathol. 7:4930–4937. 2014.PubMed/NCBI
|
|
37
|
Fan Y, Mao R, Yu Y, Liu S, Shi Z, Cheng J,
Zhang H, An L, Zhao Y, Xu X, et al: USP21 negatively regulates
antiviral response by acting as a RIG-I deubiquitinase. J Exp Med.
211:313–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamamoto M, Taguchi Y, Ito-Kureha T, Semba
K, Yamaguchi N and Inoue J: NF-κB non-cell-autonomously regulates
cancer stem cell populations in the basal-like breast cancer
subtype. Nat Commun. 4:22992013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bhola NE, Balko JM, Dugger TC, Kuba MG,
Sánchez V, Sanders M, Stanford J, Cook RS and Arteaga CL: TGF-β
inhibition enhances chemotherapy action against triple-negative
breast cancer. J Clin Invest. 123:1348–1358. 2013. View Article : Google Scholar : PubMed/NCBI
|
